Connecting People With Diabetes to Clinical Research That Matters

Review ongoing clinical trials, surveys, and research opportunities from trusted biotech and medical research partners.

Find us

Essex Junction, VT 0452, USA

Email us

ginger@diabetesnerd.com

,

Beta Cell Transplant Without Immunosuppression

  • By Ginger Vieira
  • January 7, 2025
  • 319 Views

Sana Biotechnology has taken donated islet cells and re-engineered them to be safely transplanted into a person with type 1 diabetes, eliminating the need for daily immunosuppression therapy.

Sana was able to edit the donated islet cells so they can produce insulin in the recipient without the need for daily immunosuppression therapy.

Within four weeks of transplantation, the cells remained healthy and continued to produce insulin.

Read the full press release here from Breakthrough T1D: https://bit.ly/40mEuLj